CJ-30039

· HK inno.N Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CJ-30039, covering 2017-01-02 to 2017-01-02. Get the full timeline:

Most recent: Clinical Trial Update: To Compare Safety and Pharmacokinetic Properties of CJ-30039 and Lipidil Supra [Phase 1]